Wristband could change how we track high blood pressure

NCT ID NCT06356077

Completed Knowledge-focused Sponsor: Aktiia SA Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study looked at how blood pressure changes over 12 weeks in 1,729 adults with hypertension who used the Aktiia 24/7 optical blood pressure monitor. The device is a wristband that measures blood pressure continuously without a cuff. Researchers also asked participants which monitoring method they preferred: the Aktiia bracelet, a home blood pressure monitor, or a 24-hour ambulatory monitor. The goal was to gather information, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aktiia 24/7 optical blood pressure monitoring (OBPM) device
What this could lead to: If successful, this study could show that continuous optical blood pressure monitoring is a practical and preferred way to track hypertension at home.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove that using the device improves health outcomes, and results may not apply to all people with high blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION

Contacts and locations

Locations

Lindus Health

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.